Menu
Latest News
Amplidiag® Stool Parasites featured in a presentation at the 6th International Giardia & Cryptosporidium Conference
26 Apr 2017

We are pleased to announce that Mobidiag’s Amplidiag® Stool Parasites test will be featured during the event in the presentation: “Real-time PCR procedure for Cryptosporidium spp. detection in human stools: a multi centric evaluation”.

Read More Mobidiag featured in this month's issue of Practical Patient Care magazine
19 Apr 2017

In this article, Sakari Jokiranta, MD, PhD, specialist in clinical microbiology and medical director of United Medix Laboratories – a client of the group explains what makes Mobidiag’s Amplidiag® diagnostics solutions so unique.

Read More Mobidiag Secures Additional 3.99 Million Euros in Capital Increase with Kansalaisrahoitus’ Public Financing Round
18 Apr 2017

Mobidiag Ltd. announced today that it has successfully completed a 3,99 million euros funding supported by the Finnish investment service company Kansalaisrahoitus Oy. Adding up to the loan of 15 million euros from the European Investment Bank (EIB), this new funding was completed before closing date by over 300 investors.

Read More
E
E
E
N
Amplidiag® Stool Parasites featured in a presentation at the 6th International Giardia & Cryptosporidium Conference 26 Apr 2017

We are pleased to announce that Mobidiag’s Amplidiag® Stool Parasites test will be featured during the event in the presentation: “Real-time PCR procedure for Cryptosporidium spp. detection in human stools: a multi centric evaluation”.

Read More
N
Mobidiag featured in this month’s issue of Practical Patient Care magazine 19 Apr 2017

In this article, Sakari Jokiranta, MD, PhD, specialist in clinical microbiology and medical director of United Medix Laboratories – a client of the group explains what makes Mobidiag’s Amplidiag® diagnostics solutions so unique.

Read More
N
Mobidiag Secures Additional 3.99 Million Euros in Capital Increase with Kansalaisrahoitus’ Public Financing Round 18 Apr 2017

Mobidiag Ltd. announced today that it has successfully completed a 3,99 million euros funding supported by the Finnish investment service company Kansalaisrahoitus Oy. Adding up to the loan of 15 million euros from the European Investment Bank (EIB), this new funding was completed before closing date by over 300 investors.

Read More
N
Amplidiag® tests featured in oral presentations and posters at ECCMID 2017 13 Apr 2017

Mobidiag will be attending the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria, April 22 – 25, 2017. Attend oral presentation and poster sessions to learn more about our Amplidiag® IVD tests.

Read More
E
ECCMID 2017, Vienna, Austria 11 Apr 2017

Mobidiag will be attending the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria, April 22 – 25, 2017.

Read More
N
Mobidiag Signs Agreement with AB ANALITICA for the Distribution of Amplidiag® Diagnostic Tests and Instrument in Italy 06 Apr 2017

Mobidiag Ltd today announced an agreement with AB ANALITICA, specialized in the development and the sale of diagnostic systems for professional use, for the distribution of the Amplidiag® product line.

Read More
E
JNI, Saint Malo, France 04 Apr 2017

Mobidiag sera présent aux 18e Journées Nationales d’Infectiologie (JNI), qui se tiendront à Saint Malo, France, 21-23 juin, 2017.

Read More
E
Mikrobiologiskt vårmöte och Infektionsveckan, Örlogsstaden Karlskrona, Sweden 04 Apr 2017

Mobidiag will be attending the Mikrobiologiskt vårmöte och Infektionsveckan (Infection Week and Microbiology Spring Meeting), which will take place in Örlogsstaden Karlskrona, Sweden, May 16-19, 2017.

Read More
N
Mobidiag Pursues its Growth with New Offices in United Kingdom and Appoints Stuart Cranmer as Managing Director 27 Mar 2017

Mobidiag Ltd today announced the opening of a new office in United Kingdom and the appointment of Stuart Cranmer as Managing Director to lead the business in one of the most strategic markets for Mobidiag.

Read More
E
E
Congrès SFP / SFMM, Toulouse, France 17 Mar 2017

Mobidiag sera présent au stand n°18 lors du congrès annuel des Sociétés Françaises de Parasitologie et de Mycologie Médicale (SFP / SFMM). L’évènement se tiendra à Toulouse – Centre P. Paul Riquet CHU Purpan, les 29-31 mars 2017.

Read More
N
Infektiotautien ja superbakteerien diagnostiikkayritys Mobidiagille Tekesiltä 1,2 miljoonaa lisärahoitusta 17 Mar 2017

Mobidiag Oy, suomalainen molekyylidiagnostiikan yritys julkisti tänään saaneensa 1,2 miljoonan lisärahoituksen Tekesiltä, suomalaiselta innovaatiotoiminnan rahoittajalta.

Read More
N
Mobidiag Granted Patents Covering the Method and related Kit for Detecting Antibiotic Resistant Bacteria 15 Mar 2017

Mobidiag Ltd today announced the issuance of two new patents covering a method and a kit for detecting antibiotic resistant bacteria, and more specifically, screening for carbapenemase genes causing carbapenem resistance in bacteria.

Read More
E
JFHOD 2017, Paris, France 09 Mar 2017

Mobidiag sera présent lors des JFHOD (Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive), congrès francophone de référence des maladies et cancers de l’appareil digestif. L’évènement se tiendra à Paris au Palais des congrès – Porte Maillot, les 23-26 mars.

 

Read More
E
Dansk Selskab for Klinisk Mikrobiologi årsmøde, Nyborg, Denmark 13 Feb 2017

Mobidiag will be attending the Dansk Selskab for Klinisk Mikrobiologi årsmøde, which will take place in Nyborg, Denmark, March 10-11, 2017.

Read More
N
Mobidiag Announces Release of Amplidiag® Easy, a Proprietary Molecular extraction and PCR Setup System directly from Stool Samples 23 Jan 2017

Mobidiag Ltd today announced the CE-IVD marking of Amplidiag® Easy, a proprietary system allowing nucleic acid extraction and PCR setup directly from stool samples. The Amplidiag® Easy provides users with an automated solution accelerating the sample to result time.

Read More
E
25ème Journée du GEFH, Paris, France 20 Jan 2017

Mobidiag sera présent lors de la 25ème Journée d’Actualités consacrée aux bactéries du genre Helicobacter. L’évènement, organisé par le GEFH (Groupe d’Etudes Français des Helicobacter), se tiendra à Paris à l’Hôpital Cochin, le 27 janvier 2017.

Read More